Posted Jan. 6, 2017 at 3:41 p.m.

Premium Lock Durham's GeneCentric lands Bristol-Myers Squibb buy-in

Published: 2017-01-06 15:41:12
Updated: 2017-01-06 15:41:12

GeneCentric CEO Myla Lai-Goldman, M.D. GeneCentric CEO Myla Lai-Goldman, M.D. (GeneCentric photo)

Durham’s GeneCentric Diagnostics has received an undisclosed sum of equity funding for a biomarker research collaboration with pharmaceutical giant Bristol-Myers Squibb....



Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders